[Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation].
An unusual new syndrome of eosinophilia and myalgia linked with the ingestion of L-tryptophan has recently been recorded in the USA. Some of the cases were lethal. In this report we describe a severe case of eosinophilia-myalgia syndrome observed in a woman in Switzerland who fortunately recovered after one and a half years' duration. Thus far it is not clear if L-tryptophan or a contamination of the tryptophan is the cause of the syndrome.
Frick
P
P
Medizinische Klinik, Universitätsspital Zürich.
Frey
R
R
D003937:Diagnosis, Differential; D004802:Eosinophilia / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced* / Q000175:diagnosis; D010146:Pain / Q000139:chemically induced; D012595:Scleroderma, Systemic / Q000175:diagnosis; D013577:Syndrome; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan
Eosinophilie-Myalgie-Syndrom nach Einnahme eines L-Tryptophan-haltigen Präparates.